APA

McElyea S. D., Starbuck J. M., Tumbleson-Brink D. M., Harrington E., Blazek J. D., Ghoneima A., Kula K. & Roper R. J. (20180213). Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome. : Human molecular genetics.

Chicago

McElyea Samantha D, Starbuck John M, Tumbleson-Brink Danika M, Harrington Emily, Blazek Joshua D, Ghoneima Ahmed, Kula Katherine and Roper Randall J. 20180213. Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome. : Human molecular genetics.

Harvard

McElyea S. D., Starbuck J. M., Tumbleson-Brink D. M., Harrington E., Blazek J. D., Ghoneima A., Kula K. and Roper R. J. (20180213). Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome. : Human molecular genetics.

MLA

McElyea Samantha D, Starbuck John M, Tumbleson-Brink Danika M, Harrington Emily, Blazek Joshua D, Ghoneima Ahmed, Kula Katherine and Roper Randall J. Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome. : Human molecular genetics. 20180213.